Daily serum and salivary BDNF levels correlate with morning-evening personality type in women and are affected by light therapy

Rivista di Psichiatria

Volumn 47, Issue 6, 2012, Pages 527-534

  Tirassa, Paola ^a   Iannitelli, Angela ^b   Sornelli, Federica ^a   Cirulli, Francesca ^c   Mazza, Monica ^d   Calza, Arianna ^a   Alleva, Enrico ^c   Branchi, Igor ^c   Aloe, Luigi ^a   Bersani, Giuseppe ^b   Pacitti, Francesca ^c  

^a CNR   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Circadian rhythms; Light therapy; Major depression; Morning evening personality type; Peripheral markers; Salivary BDNF; Serum BDNF

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; ANXIETY; ARTICLE; DEPRESSION; FEMALE; HUMAN; HUMAN EXPERIMENT; MORNING EVENING PERSONALITY TYPE; NORMAL HUMAN; PERSONALITY; PHOTOTHERAPY; PROTEIN BLOOD LEVEL; SALIVA LEVEL;

ADULT; BIOLOGICAL CLOCKS; BIOLOGICAL MARKERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CIRCADIAN RHYTHM; DEPRESSION; FEMALE; HUMANS; PERSONALITY; PERSONALITY INVENTORY; PHOTOTHERAPY; SALIVA; SAMPLING STUDIES; STATISTICS, NONPARAMETRIC; STRESS, PSYCHOLOGICAL; STUDENTS;

EID: 84871576445     PISSN: 00356484     EISSN: None     Source Type: Journal    
DOI: 10.1708/1183.13096     Document Type: Article

References (58)

1. Lipsky RH, Marini AM. Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity. Ann NY Acad Sci 2007; 1122: 130-43. (Pubitemid 350249544)
2. Waterhouse EG, Xu B. New insights into the role of brain-derived neurotrophic factor in synaptic plasticity. Mol Cell Neurosci 2009; 42: 81-9.
3. Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006; 59: 1116-27.
4. Cirulli F, Alleva E. The NGF saga: from animal models of psychosocial stress to stress-related psychopathology. Front Neuroendocrinol 2009; 30: 379-95.
5. Calabrese F, Molteni R, Recagni G, Riva MA. Neuronal plasticity: a link between stress and mood disorders. Psychoneuroendocrinology 2009; 34 (Suppl 1): S208-16.
6. Hashimoto K, Shimizu E, Iyo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Brain Res Rev 2004; 45: 104-14. (Pubitemid 38625738)
7. Tsai SJ, Hong CJ, Liou YJ. Brain-derived neurotrophic factor and antidepressant action: another piece of evidence from pharmacogenetics. Pharmacogenomics 2008; 9: 1353-8.
8. Castren E, Rantamaki T. The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity. Dev Neurobiol 2010; 70: 289-97.
9. Sen S, Duman R, Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 2008; 64: 527-32.
10. Lang UE, Hellweg R, Gallinat J. BDNF serum concentrations in healthy volunteers are associated with depression-related personality traits. Neuropsychopharmacology 2004; 29: 795-8. (Pubitemid 38402487)
11. Lang UE, Hellweg R, Gallinat J. Association of BDNF serum concentrations with central serotonergic activity: evidence from auditory signal processing. Neuropsychopharmacology 2005; 30: 1148-53. (Pubitemid 40720973)
12. Currie J, Ramsbottom R, Ludlow H, Nevill A, Gilder M. Cardiorespiratory fitness, habitual physical activity and serum brain derived neurotrophic factor (BDNF) in men and women. Neurosci Lett 2009; 451: 152-5.
13. Nofuji Y, Suwa M, Moriyama Y, et al. Decreased serum brain-derived neurotrophic factor in trained men. Neurosci Lett 2008; 437: 29-32.
14. Chan KL, Tong KY, Yip SP. Relationship of serum brain-derived neurotrophic factor (BDNF) and health-related lifestyle in healthy human subjects. Neurosci Lett 2008; 447: 124-8.
15. Terman M, Terman JS. Light therapy for seasonal and nonseasonal depression: efficacy, protocol, safety, and side effects. CNS Spectr 2005; 10: 647-63. (Pubitemid 41232548)
16. Liang FQ, Walline R, Earnest DJ. Circadian rhythm of brain-derived neurotrophic factor in the rat suprachiasmatic nucleus. Neurosci Lett 1998; 242: 89-92. (Pubitemid 28084300)
17. Schaaf MJ, Duurland R, de Kloet ER, Vreugdenhil E. Circadian variation in BDNF mRNA expression in the rat hippocampus. Brain Res Mol Brain Res 2000; 75: 342-4. (Pubitemid 30109287)
18. Iannitelli A, Pacitti F, Aloe L, Bersani G. Studio preliminare del ritmo ultradiano dei livelli ematici del Brain-Derived Neurotrophic Factor (BDNF) in soggetti schizofrenici e controlli sani. Riv Psichiatr 2007; 42: 391-7.
19. Castro M, Elias PC, Martinelli CE Jr, Antonini SR, Santiago L, Moreira AC. Salivary cortisol as a tool for physiological studies and diagnostic strategies. Braz J Med Biol Res 2000; 33: 1171-5.
20. Zawilska JB, Skene DJ, Arendt J. Physiology and pharmacology of melatonin in relation to biological rhythms. Pharmacol Rep 2009; 61: 383-410.
21. Bersani G, Mameli M, Garavini A, Pancheri P, Nordio M. Reduction of night/day difference in melatonin blood levels as a possible disease-related index in schizophrenia. Neuro Endocrinol Lett 2003; 24: 181-4. (Pubitemid 37074810)
22. Ciarleglio CM, Resuehr HE, McMahon DG. Interactions of the serotonin and circadian systems: nature and murture in rhytms and blues. Neuroscience 2011; 197: 8-16.
23. Bersani G, Iannitelli A, Massoni E, et al. Ultradian variation of nerve growth factor plasma levels in healthy and schizophrenic subjects. Int J Immunopathol Pharmacol 2004; 17: 367-72. (Pubitemid 39481679)
24. Magnusson A. Validation of the Seasonal Pattern Assessment Questionnaire (SPAQ). J Affect Disord 1996; 40: 121-9. (Pubitemid 26338510)
25. Aalto AM, Elovainio M, Kivimäki M, Uutela A, Pirkola S. The Beck Depression Inventory and General Health Questionnaire as measures of depression in the general population: a validation study using the Composite International Diagnostic Interview as the gold standard. Psychiatry Res 2012; 197: 163-71.
26. Oei TP, Evans L, Crook GM. Utility and validity of the STAI with anxiety disorder patients. Br J Clin Psychol 1990; Pt 4: 429-32.
27. Bagby RM, Taylor GJ, Ryan D. Toronto Alexithymia Scale: relationship with personality and psychopathology measures. Psychother Psychosom 1986; 45: 207-15. (Pubitemid 17049328)
28. Horne JA, Ostberg O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol 1976; 4: 97-110. (Pubitemid 8001177)
29. Siminoski K, Bernanke J, Murphy RA. Nerve growth factor and epidermal growth factor in mouse submandibular glands: identical diurnal changes and rates of secretagogue-induced synthesis. Endocrinology 1993; 132: 2031-7. (Pubitemid 23133250)
30. Komatsu K, Hasegawa H, Honda T, Yabashi A, Kawasaki T. Nerve growth factor in saliva stimulated by mastication. Oral Sci Int 2008; 5: 78-84.
31. Begliuomini S, Lenzi E, Ninni F, et al. Plasma brain-derived neurotrophic factor daily variations in men: correlation with cortisol circadian rhythm. J Endocrinol 2008; 197: 429-35. (Pubitemid 351696256)
32. Piccinni A, Marazziti D, Del Debbio A, et al Diurnal variation of plasma brain-derived neurotrophic factor (BDNF) in humans: an analysis of sex differences. Chronobiol Int 2008; 25: 819-26.
33. Pluchino N, Cubeddu A, Begliuomini S, et al. Daily variation of brain-derived neurotrophic factor and cortisol in women with normal menstrual cycles, undergoing oral contraception and in postmenopause. Hum Reprod 2009; 24: 2303-9.
34. Lommatzsch M, Zingler D, Schuhbaeck K, et al. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging 2005; 26: 115-23. (Pubitemid 39600596)
35. Hellweg R, Ziegenhorn A, Heuser I, Deuschle M. Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment. Pharmacopsychiatry 2008; 41: 66-71. (Pubitemid 351427525)
36. Bus BA, Molendijk ML, Penninx BJ, et al. Determinants of serum brain-derived neurotrophic factor. Psychoneuroendocrinology 2011; 36: 228-39.
37. Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006; 59: 1116-27.
38. Natale V, Cicogna PC. Morningness-eveningness dimension: is it really a continuum? Personality and Individual Differences 2002; 32: 809-16.
39. Cavallera G, Giudici S. Morningness and eveningness personality: a survey in literature from 1995 up till 2006. Personality and Individual Differences 2008; 44: 3-21.
40. Bailey SL, Heitkemper MM. Morningness-eveningness and early-morning salivary cortisol levels. Biol Psychol 1991; 32: 181-92.
41. Willis TA, O'Connor DB, Smith L. The influence of morningness-eveningness on anxiety and cardiovascular responses to stress. Physiol Behav 2005; 85: 125-33. (Pubitemid 40733241)
42. Hidalgo MP, Caumo W, Posser M, Coccaro SB, Camozzato AL, Chaves ML. Relationship between depressive mood and chronotype in healthy subjects. Psychiatry Clin Neurosci 2009; 63: 283-90.
43. Gaspar-Barba E, Calati R, Cruz-Fuentes CS, et al. Depressive symptomatology is influenced by chronotypes. J Affect Disord 2009; 119: 100-6.
44. Selvi Y, Aydin A, Boysan M, Atli A, Agargun MY, Besiroglu L. Associations between chronotype, sleep quality, suicidality, and depressive symptoms in patients with major depression and healthy controls. Chronobiol Int 2010; 27: 1813-28.
45. Lee HY, Kim YK. Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants. Neuropsychobiology 2008; 57: 194-9.
46. Fujimura H, Altar CA, Chen R, et al. Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost 2002; 87: 728-34. (Pubitemid 34302963)
47. Radka SF, Holst PA, Fritsche M, Altar CA. Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay. Brain Res 1996; 709: 122-301.
48. Chaldakov GN, Fiore M, Stankulov IS, et al. Neurotrophin presence in human coronaryatherosclerosis and metabolic syndrome: a role for NGF and BDNF in cardiovascular disease? Prog Brain Res 2004; 146: 279-89. (Pubitemid 37541389)
49. Givalois L, Marmigère F, Rage F, Ixart G, Arancibia S, Tapia-Arancibia L. Immobilization stress rapidly and differentially modulates BDNF and TrkB mRNA expression in the pituitary gland of adult male rats. Neuroendocrinology 2001; 74: 148-59. (Pubitemid 32786214)
50. Karege F, Schwald M, Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain platelets. Neurosci Lett 2002; 328: 261-4. (Pubitemid 34876661)
51. Lang UE, Hellweg R, Seifert F, Schubert F, Gallinat J. Correlation between serum brain-derived neurotrophic factor level and in vivo marker of cortical integrity. Biol Psychiatry 2007; 62: 530-5. (Pubitemid 47284037)
52. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 1998; 37: 1553-61. (Pubitemid 28550429)
53. Tsukinoki K, Saruta J, Sasaguri K, et al. Immobilization stress induces BDNF in rat submandibular glands. J Dent Res 2006; 85: 844-8. (Pubitemid 44409036)
54. Partlow LM, Wallace LJ, Wardell LJ. Nerve growth factor and an anticomplimentary protease in mouse saliva elicited by nerve stimulation. J Physiol 1981; 310: 1-11. (Pubitemid 11166815)
55. Wallace LJ, Partlow LM. Alpha-adrenergic regulation of secretion of mouse saliva rich in nerve growth factor. Proc Natl Acad Sci USA 1976; 73: 4210-4.
56. Bellavia SL, Gallara RV. Modification of the beta- and alpha2-adrenergic sensitivity of rat submandibular glands by environmental stimuli and stress. Arch Oral Biol 1998; 43: 933-39. (Pubitemid 28551241)
57. Bergdahl M, Bergdahl J. Low unstimulated salivary flow and subjective oral dryness: association with medication, anxiety, depression, and stress. J Dent Res 2000; 79: 1652-58. (Pubitemid 32489429)
58. Kopittke L, Gomez R, Barros HM. Opposite effects of antidepressants on unstimulated and stimulated salivary flow. Arch Oral Biol 2005; 50: 17-21. (Pubitemid 39623081)